The thromboelastography G parameter as a potential biomarker of acute coronary syndrome

References

• Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;12:100.
   Google Scholar
• Dries D. The contemporary role of blood products and components used in trauma resuscitation. Scand J Trauma Resusc Emerg Med. 2010;18(1):63.
   PubMedGoogle Scholar
• Salooja N, Perry P. Thrombelastography. Blood Coagul Fibrinolysis. 2001;12(5):327–337.
   PubMed Web of Science ®Google Scholar
• Vig S, Chitolie A, Bevan DH, et al. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis. 2001;12(7):555–561.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999–3054.
   PubMed Web of Science ®Google Scholar
• Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg. 2000;90(5):1086–1088.
   PubMed Web of Science ®Google Scholar
• Zambruni A, Thalheimer U, Leandro G, et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis. 2004;15(1):103–107.
   PubMed Web of Science ®Google Scholar
• Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects thrombelastograph analysis. Anesthesiology. 2000;92(5):1242–1249.
   PubMed Web of Science ®Google Scholar
• Koestenberger M, Gallistl S, Muntean W, et al. An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography. Blood Coagul Fibrinolysis. 2005;16(8):613–617.
   PubMed Web of Science ®Google Scholar
• Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–1513.
   PubMed Web of Science ®Google Scholar
• Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 2003;107(22):2786–2792.
   PubMed Web of Science ®Google Scholar
• Breet NJ, van Werkum JW, Bouman HJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA. 2010;303(8):754–762.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, et al. Clopidogrel in unstable angina to prevent recurrent events trial investigators.effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494–502.
   PubMed Web of Science ®Google Scholar
• Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1607–1621.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Cannon CP, Gibson CM, et al. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179–1189.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987;258(9):1183–1186.
   PubMed Web of Science ®Google Scholar
• Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294(14):1799–1809.
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320.
   PubMed Web of Science ®Google Scholar
• Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl 2):E1–40.
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454.
   PubMed Web of Science ®Google Scholar
• Stefanadi E, Tousoulis D, Papageorgiou N, et al. Inflammatory biomarkers predicting events in atherosclerosis. CMC. 2010;17(16):1690–1707.
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Braun S, King L, et al. Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2013;111(6):804–810.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu Y, Bian C, et al. Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome. Tex Heart Inst J. 2010;37(2):178–183.
   PubMed Web of Science ®Google Scholar
• Hynes R. Integrins: a family of cell surface receptors. Cell. 1987;48(4):549–554.
   PubMed Web of Science ®Google Scholar
• Ha SI, Choi DH, Ki YJ, et al. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets. 2011;22(6):408–414.
   PubMed Web of Science ®Google Scholar
• Bayar N, Arslan S, Cagirci G, et al. Usefulness of mean platelet volume for predicting stroke risk in paroxysmal atrial fibrillation patients. Blood Coagul Fibrinolysis. 2015;26(6):669–672.
   PubMed Web of Science ®Google Scholar
• Reddy SK, Shetty R, Marupuru S, et al. Significance of platelet volume indices in STEMI patients: a case-control study. J Clin Diagn Res. 2017;11(4):LC05–LC07.
   PubMed Web of Science ®Google Scholar
• Carr ME, Jr, Martin EJ, Kuhn JG, et al. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa. Clin Lab. 2004;50(9–10):529–538.
   PubMedGoogle Scholar
• Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252(3):434–442.
   PubMed Web of Science ®Google Scholar
• Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg. 2000;91(1):35–39.
   PubMed Web of Science ®Google Scholar
• Lang T, von Depka M. Possibilities and limitations of thromboelastometry/thromboelastography. Hamostaseologie. 2006;26(3 Suppl 1):S20–S29.
   PubMedGoogle Scholar